FULC
FULC
NASDAQ · Pharmaceuticals

Fulcrum Therapeutics Inc

$7.01
+0.13 (+1.89%)
As of May 10, 10:18 PM ET ·
Analyst Consensus
Strong Buy
16
Analysts
High
Coverage
Buy 13 81%
Hold 2 13%
Sell 1 6%
Price Target
Analyst Price Target +712.8% upside
Low Target $37.54
Average Target $56.98
High Target $60.88
Current Price $7.01
Current
$7.01
Target
$56.98
$37.54 $56.98 avg $60.88
Scenario Analysis
Bear Case
$37.54
435.5%
Low target
Base Case
$56.98
+712.8%
Avg target
Bull Case
$60.88
+768.5%
High target
Risk/Reward
1.8x
Balanced
Price in Context
52-Week High
$15.74
-55.5% from high
52-Week Low
$4.78
+46.8% from low
Target vs 52W High
$56.98
+262.0% vs high
Peer Consensus — Pharmaceuticals
Stock Consensus Analysts Buy % Target Upside
RDY
Dr. Reddy's Laboratories
Hold 45 51% +0.0%
LLY
Eli Lilly and Co.
Strong Buy 39 77% $1,330.33 +40.3%
JNJ
Johnson & Johnson
Buy 32 63% $299.55 +35.3%
MRK
Merck & Co. Inc.
Buy 35 71% $159.27 +43.0%
PFE
Pfizer Inc.
Hold 36 44% $33.90 +32.0%
BMY
Bristol-Myers Squibb Co
Hold 36 42% $174.50 +210.7%
ZTS
Zoetis Inc
Buy 25 60% $209.87 +153.4%
RPRX
Royalty Pharma Plc- Cl A
Strong Buy 16 88% $36.26 -28.6%